Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term Debt
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Payables: 2020-2025

Historic Payables for Mainz Biomed N.V (MYNZ) over the last 1 years, with Jun 2025 value amounting to $596,886.

  • Mainz Biomed N.V's Payables fell 63.89% to $596,886 in Q2 2025 from the same period last year, while for Jun 2025 it was $6.7 million, marking a year-over-year decrease of 26.38%. This contributed to the annual value of $1.3 million for FY2024, which is 60.61% down from last year.
  • Latest data reveals that Mainz Biomed N.V reported Payables of $596,886 as of Q2 2025, which was down 52.41% from $1.3 million recorded in Q4 2024.
  • In the past 5 years, Mainz Biomed N.V's Payables registered a high of $3.2 million during Q4 2023, and its lowest value of $503,181 during Q2 2022.
  • Moreover, its 3-year median value for Payables was $1.5 million (2023), whereas its average is $1.7 million.
  • In the last 5 years, Mainz Biomed N.V's Payables surged by 445.23% in 2023 and then tumbled by 63.89% in 2025.
  • Over the past 5 years, Mainz Biomed N.V's Payables (Quarterly) stood at $807,540 in 2021, then spiked by 236.49% to $2.7 million in 2022, then rose by 17.19% to $3.2 million in 2023, then plummeted by 60.61% to $1.3 million in 2024, then tumbled by 63.89% to $596,886 in 2025.
  • Its Payables was $596,886 in Q2 2025, compared to $1.3 million in Q4 2024 and $1.7 million in Q2 2024.